Randomized, double-blind, active-controlled study evaluating the safety and immunogenicity of three vaccination schedules and two dose levels of AV7909 vaccine for anthrax post-exposure prophylaxis in healthy adults - Hopkins, Robert J.; Kalsi, Gurdyal; Montalvo-Lugo, Victor M.; Sharma, Mona; Wu, Yukun; Muse, Derek D.; Sheldon, Eric A.; Hampel, Frank C.; Lemiale, Laurence (Vaccine, 2016)
Keywords: Adjuvants, Immunologic - administration & dosage; Adult; adults; Allergy and Immunology; Anthrax; Anthrax - prevention & control; Anthrax Vaccines - administration & dosage; Anthrax Vaccines - adverse effects; Anthrax Vaccines - therapeutic use; Antibodies, Bacterial - blood; Antibodies, Neutralizing - blood; Antigens; BioThrax® (Anthrax Vaccine Adsorbed); Blood pressure; CPG 7909; disease control; Double-Blind Method; Drug dosages; etiology; Female; Hispanic Americans; Humans; Immune response; Immunization Schedule; Immunogenicity; Infections; Investigations; Male; Middle Aged; neutralization; neutralizing antibodies; Oligodeoxyribonucleotides - administration & dosage; Post-exposure prophylaxis; Post-Exposure Prophylaxis - methods; Prophylaxis; Safety; Toxins; Urine; vaccination; Vaccine; Vaccines; Young Adult; United States--US; BioThrax® (Anthrax Vaccine Adsorbed); Vaccine; Post-exposure prophylaxis; NCT01770743; Anthrax; CPG 7909; BioThrax ® (Anthrax Vaccine Adsorbed); BioThrax(®) (Anthrax Vaccine Adsorbed)